Still No Clarity on Women’s Health Initiative Funding
What: Despite claims, WHI funding remains frozen pending federal decisions.
Key Line: “Nothing has changed contractually,” said an official to WHI’s coordinating center.
A former NIH director calls for institutional changes to better prioritize female health.
Even with dye bans, ultra-processed food remains the real issue, The Atlantic argues.
Cosmo breaks down Botox alternatives—and why your injector matters most.
NPR adds more detail to WHI’s shutdown and the loss of 1990s-era women’s health data.
Makary says he won’t act on mifepristone for now, but is “awaiting more data.”
Vox explores new science to delay menopause—and whether we should.
Cardiology experts warn cutting WHI would jeopardize sex-specific research advances.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
Meta-analysis finds prenatal cannabis use raises risks of preterm and low birth weight.
Drew Altman breaks down the real-world consequences of Kennedy’s sweeping HHS overhaul.
WBUR spotlights MAP volunteers mailing abortion meds to banned states.
NIH, NSF, and women’s health research all targeted in proposed budget.
ACOG proposes fewer but longer prenatal visits to improve care for low-risk pregnancies.
Women under 50 are 40% less likely than men to get early transfusions after trauma.
New data shows fertilizing 7–9 eggs is ideal for live births and minimizing excess embryos.
A major study ties maternal diabetes to neurodevelopmental issues in children.
Cancer incidence among women continues to rise despite overall progress.
Cosmo breaks down Botox alternatives—and why your injector matters most.
A former NIH director calls for institutional changes to better prioritize female health.
Study finds real increases in maternal mortality, especially post-COVID, even accounting for reporting changes.